These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15355566)

  • 1. Osteopontin-deficiency suppresses growth of B16 melanoma cells implanted in bone and osteoclastogenesis in co-cultures.
    Ohyama Y; Nemoto H; Rittling S; Tsuji K; Amagasa T; Denhardt DT; Nifuji A; Noda M
    J Bone Miner Res; 2004 Oct; 19(10):1706-11. PubMed ID: 15355566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues.
    Nemoto H; Rittling SR; Yoshitake H; Furuya K; Amagasa T; Tsuji K; Nifuji A; Denhardt DT; Noda M
    J Bone Miner Res; 2001 Apr; 16(4):652-9. PubMed ID: 11315992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6.
    Chen GL; Luo Y; Eriksson D; Meng X; Qian C; Bäuerle T; Chen XX; Schett G; Bozec A
    Oncotarget; 2016 May; 7(18):26653-69. PubMed ID: 27049717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy.
    Yamate T; Mocharla H; Taguchi Y; Igietseme JU; Manolagas SC; Abe E
    Endocrinology; 1997 Jul; 138(7):3047-55. PubMed ID: 9202251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone.
    Asou Y; Rittling SR; Yoshitake H; Tsuji K; Shinomiya K; Nifuji A; Denhardt DT; Noda M
    Endocrinology; 2001 Mar; 142(3):1325-32. PubMed ID: 11181551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin is required for mechanical stress-dependent signals to bone marrow cells.
    Ishijima M; Tsuji K; Rittling SR; Yamashita T; Kurosawa H; Denhardt DT; Nifuji A; Ezura Y; Noda M
    J Endocrinol; 2007 May; 193(2):235-43. PubMed ID: 17470514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.
    Hayashi C; Rittling S; Hayata T; Amagasa T; Denhardt D; Ezura Y; Nakashima K; Noda M
    J Cell Biochem; 2007 Jul; 101(4):979-86. PubMed ID: 17390343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.
    Natasha T; Kuhn M; Kelly O; Rittling SR
    Am J Pathol; 2006 Feb; 168(2):551-61. PubMed ID: 16436669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells.
    Li M; Amizuka N; Takeuchi K; Freitas PH; Kawano Y; Hoshino M; Oda K; Nozawa-Inoue K; Maeda T
    Microsc Res Tech; 2006 Feb; 69(2):73-83. PubMed ID: 16456838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
    Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
    J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis.
    Matsumoto HN; Tamura M; Denhardt DT; Obinata M; Noda M
    Endocrinology; 1995 Sep; 136(9):4084-91. PubMed ID: 7544276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.
    Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N
    J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium deficiency results in an increased formation of osteoclasts.
    Belluci MM; Schoenmaker T; Rossa-Junior C; Orrico SR; de Vries TJ; Everts V
    J Nutr Biochem; 2013 Aug; 24(8):1488-98. PubMed ID: 23517915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation.
    Kitahara K; Ishijima M; Rittling SR; Tsuji K; Kurosawa H; Nifuji A; Denhardt DT; Noda M
    Endocrinology; 2003 May; 144(5):2132-40. PubMed ID: 12697722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells.
    Takita M; Inada M; Maruyama T; Miyaura C
    FEBS Lett; 2007 Feb; 581(3):565-71. PubMed ID: 17254571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.
    Chikatsu N; Takeuchi Y; Tamura Y; Fukumoto S; Yano K; Tsuda E; Ogata E; Fujita T
    Biochem Biophys Res Commun; 2000 Jan; 267(2):632-7. PubMed ID: 10631114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.
    Abu-Amer Y; Ross FP; Edwards J; Teitelbaum SL
    J Clin Invest; 1997 Sep; 100(6):1557-65. PubMed ID: 9294124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
    Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
    J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.